We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Simple Affordable Diagnostic Kit Developed for Chikungunya

By LabMedica International staff writers
Posted on 11 Nov 2015
Chikungunya (CHIKV), a mosquito-borne illness that while not often deadly causes severe, incapacitating and often chronic joint pain, is spreading globally and it can be difficult to diagnose and most tests available now are expensive and challenging to develop.

An innovative approach has been developed for the production of alphavirus antigens for use in diagnostic assays that results in reduced production complexity as well as improved sensitivity in application. More...
The insect-specific nature of these chimeric viruses yields an advantageous safety profile and allows for safe handling of the antigen at the bench top.

Scientists at the University of Texas Medical Branch (Galveston, TX, USA) and their colleagues were able to use another mosquito-borne virus that had remained largely unknown and unstudied to create the new test that could help doctors and investigators diagnose and track the spread of chikungunya. The formerly unknown virus, now named Eilat virus (EILV), is related to chikungunya and other mosquito-borne viruses and was collected in Israel's Negev Desert about three decades ago. The virus will only replicate in mosquitoes, which makes it harmless to humans and other vertebrates.

The team worked with the private commercial laboratory InBios International (Seattle, WA, USA), and used the Eilat virus-based chimera to create a safe and simple-to-use diagnostic test. Health care professionals are able to take the serum of those suspected of being infected with chikungunya and, using the diagnostic test kit created in conjunction with InBios, have a result in less than two hours. To test the assay for immunoglobulin (IgM) enzyme-linked immunosorbent assay (ELISA) positive controls, a panel of five IgM/ELISA and plaque reduction neutralization test (PRNT)-positive convalescent sera obtained from patients diagnosed by reverse transcriptase-PCR with CHIKV infection was used. Eight human serum samples positive for either Dengue virus (DENV) or Venezuelan equine encephalitis virus (VEEV) but negative for CHIKV by hemagglutination inhibition (HI) were used as negative controls. Absorbance values for ELISAs were read at 450 nm on a VERSAmax tunable microplate reader (Molecular Devices; Sunnyvale, CA, USA).

Anti-CHIKV IgM was readily detected with OD values ranging from 0.23 to 3.0, whereas the negative controls yielded a mean OD value of 0.09. The scientists were able to demonstrate that EILV/CHIKV replicates to high titers in insect cells and can be applied directly in enzyme-linked immunosorbent assays without inactivation, resulting in highly sensitive detection of recent and past CHIKV infection, and outperforming traditional antigen preparations. They were also able to show that that their anti-CHIKV IgM and IgG ELISAs can distinguish between human infections caused by CHIKV and VEEV or DENV with a high degree of signal separation. The study was published on October 22, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of Texas Medical Branch 
InBios International
Molecular Devices 



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.